Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor

B Mei, J Li, Z Zuo - Brain, Behavior, and Immunity, 2021 - Elsevier
Sepsis-associated encephalopathy (SAE) is a significant clinical issue that is associated
with increased mortality and cost of health care. Dexmedetomidine, an α2 adrenoceptor …
被引用次数：124 相关文章

Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor

B Mei, J Li, Z Zuo - Brain, behavior, and immunity, 2021 - pubmed.ncbi.nlm.nih.gov
Sepsis-associated encephalopathy (SAE) is a significant clinical issue that is associated
with increased mortality and cost of health care. Dexmedetomidine, an α2 adrenoceptor …
[HTML] nih.gov

[HTML][HTML] Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor

B Mei, J Li, Z Zuo - Brain, behavior, and immunity, 2021 - ncbi.nlm.nih.gov
Sepsis-associated encephalopathy (SAE) is a significant clinical issue that is associated
with increased mortality and cost of health care. Dexmedetomidine, an α2 adrenoceptor …

Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor.

B Mei, J Li, Z Zuo - Brain, Behavior, and Immunity, 2020 - europepmc.org
Sepsis-associated encephalopathy (SAE) is a significant clinical issue that is associated
with increased mortality and cost of health care. Dexmedetomidine, an α2 adrenoceptor …